Patent · US Active

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

US9919056B2 · kind B2 · utility

6Cited by

78References

12Claims

0Family size

Assignees

ADC THERAPEUTICS SA · CH
MedImmune Limited · US

Inventors

Patricius Hendrikus Cornelis Van Berkel · Épalinges, CH
Philip Wilson Howard · London, GB

Key dates

Filing date	Oct 11, 2013
Grant date	Mar 20, 2018
Priority date	—
Expiry date	Oct 11, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Conjugates of an isolated humanized, anti-CD22 antibody with PBD dimers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.